Declarations
Acknowledgments
We thank Frédérico Garnier from Agence de la biomédecine for his gracious comments.
Author contributions
SS designed the research study and wrote the manuscript. PAG, MS, VD and NV participated in the study design, corrected and approved the manuscript, and provided intellectual content of critical importance to the work.
Conflicts of interest
Pierre-Antoine Gourraud is the founder of Methodomics (2008, www.methodomics.com) and the co-founder of Wedata (2018, www.wedata.science). He is consulting for major pharmaceuticals companies all dealt with through academic pipelines (AstraZeneca, Biogen, Boston Scientific, Cook, Edimark, Ellipses, Elsevier, Methodomics, Merck, Mérieux, Sanofi-Genzyme, WeData). Pierre-Antoine Gourraud is volunteer board member at AXA Mutual Insurance Company. He has no prescription activity neither drugs nor devices.
Ethical approval
Not applicable.
Consent to participate
Informed consent to participate in the study was obtained from all participants.
Consent to publication
Informed consent to publication was obtained from all participants.
Funding
This work has been awarded a government grant managed by the National Research Agency under the program “Investissements d’avenir” with the reference KTD-Innov [ANR-17-RHUS-0010]. This project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under Grant Agreement No. 754995. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Copyright
© The Author(s) 2022.